Kenya's Mother-Daughter program aims to slash cervical cancer deaths

NCT ID NCT06411938

Ongoing Knowledge-focused Sponsor: Indiana University Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study enrolls 2,300 Kenyan women and girls to improve cervical cancer prevention. Women provide self-collected swabs for HPV testing and undergo standard visual screening. The goal is to see if self-testing is as good as or better than current methods, and to understand what helps or hinders participation. Researchers also study anogenital warts as a possible HPV reservoir.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: High Risk HPV DNA Testing (self-collected swab) and Visual Inspection with Acetic Acid (VIA)
What this could lead to: If successful, this could lead to more effective, community-based cervical cancer screening programs in Kenya, especially for HIV-infected women.
What could go wrong: This is an observational study, not a treatment trial. Results may not apply to other regions, and screening accuracy depends on many factors.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CERVICAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Uterine Cervical Neoplasms cervical cancer prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CERVICAL CANCER CERVICAL CANCER PREVENTION

Contacts and locations

Locations

Moi University

Eldoret, Kenya

More trials for these conditions

Other studies related to the condition(s) this trial covers.